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Background. The clinical presentation of desmoplastic melanoma is often challenging. We report the experience of the Melanoma
Unit of Spedali Civili University Hospital of Brescia, Italy. Method. Study subjects were drawn from 1770 patients with histologica
conﬁrmed melanoma. Within this group, desmoplastic melanoma developed in 5 patients. For each diagnosed melanoma,
histological characteristics, treatment, and outcomes were evaluated. Results. Of the 5 patients described in this study, 2 were
males and 3 females. The average age was 62.4 years ranging from 56 to 68 years. Breslow thickness ranged from 2.1 to 12mm
with a mean thickness of 5.8mm. Primary treatment of 5 patients included a wide local excision of their primary lesions.
Conclusions. Desmoplastic melanoma is a rare neoplasm which clinically may mimic other tumours or cutaneous inﬁltrate of
uncertain signiﬁcance. The diagnosis is hiastopathological and radical resection is necessary.
Copyright © 2009 A. M. Manganoni et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Background
Desmoplastic melanoma (DM) is a rare variant of malignant
melanoma ﬁrst described by Conley et al. in 1971 as an
invasive melanoma composed of spindle cells surrounded
by abundant collagen [1]. The clinical presentation of
desmoplastic melanoma is often challenging. Usually it has
an innocuous clinical appearance and it is described as
an indurated discoid papule, plaque, or nodule. It most
commonly arises in chronically sun-damaged skin. Rarely,
DM may present on a mucosal surface. We describe our
experience at Melanoma Unit of Spedali Civili University
Hospital in Brescia, Italy, with patients whose melanoma was
reported to be desmoplastic.
2.MaterialandMethods
Studysubjectsweredrawnretrospectivelyfrom1770patients
with histological conﬁrmed melanoma, including melanoma
in situ, between January 1, 1984, and January 1, 2009.
These patients were followed up by the Melanoma Unit of
Spedali Civili University Hospital in Brescia, Italy. All the
patients gave an informed consent to be entered into the
data-base. A total of 5 patients (0.3%) who had been given
a diagnosis of cutaneous desmoplastic melanoma, which
was histologically conﬁrmed, were identiﬁed (Table 1). All
patients were staged with the use of the American Joint
Committee on Cancer (AJCC) staging classiﬁcation [2]. The
patient’s sex, ethnic origin, age, and Fitzpatrick skin types
at diagnosis were recorded. For each diagnosed melanoma,
histologic classiﬁcation, anatomic location, tumor thickness
(Breslow method), Clark’s anatomical level of invasion,
ulceration, regression, neurotropism, lymphatic invasion
andnumberofmitosespersquaremillimetrewereevaluated.
Melanomas were classiﬁed as being located in the head and
neck, trunk (including chest, back, abdomen, and buttock),
upper extremity (including arm, forearm, and hand), and
lower extremity (including thigh, leg, and foot). Treatment
and outcomes were also examined.
3. Results
In the period between January 1, 1984, and January 1,
20095patientswithcutaneousdesmoplasticmelanomawere2 Dermatology Research and Practice
Table 1: Clinical features of 5 patients with cutaneous desmoplastic melanoma.
Patient no. Age (y)/Sex Fitzpatrick skin types Site Breslow depth (mm) SLNB Neurotropis m Follw-up (mos)/status
1 65/F II Upper extremity 2.4 — absent 113/Alive
2 65/F III Lower extremity 2.5 negative absent 68/Alive
3 56/M II Upper extremity 2.1 negative absent 56/Alive
4 58/F II Lower extremity 12 negative absent 5/Alive
5 68/M III Trunk 10 negative present 2/Alive
SLNB sentinel lymph node biopsy.
identiﬁed. The incidence of desmoplastic melanoma cases
in our population was 0.3% (5/1770). Of the 5 patients
evaluated, 2 were males and 3 females. All patients were
Caucasians. The average age was 62.4 years ranging from
56 to 68 years. Of the 5 documented patients, percentages
of Fitzpatrick skin types were as follows: II 60% (3pz)
and III 40% (2pz). Primary melanomas were found in
diﬀerent body sites: 1 (20%) on the trunk, 2 (40%) on
the upper extremity, and 2 (40%) on the lower extremity.
None of our 5 cases had a documented family history of
melanoma. Breslow thickness ranged from 2.1 to 12mm
with a mean thickness of 5.8mm. One patient had a lesion
with neurotropism (case 5). Primary treatment of 5 patients
included wide and deep local excision of their primary
lesions. 4 out of 5 patients underwent sentinel lymph node
biopsy (SLNB) and no patient was found to have a positive
sentinel node. Follow-up ranged from 2 to 113 months,
with an average of 49 months, and during follow-up period
any patient had disease progression or developed local
recurrence.
4. Conclusions
The incidence of desmoplastic melanoma cases in our
population was 0.3% (5/1770). Of the 5 patients evaluated,
2 (40%) were males and 3 (60%) female. This female
predominance in sex distribution is not in accordance with
previous case series [3]. The median age at diagnosis of
DM is approximately 10 years higher than the one for
conventional melanoma [4]. In our case the average age
was 62.4 years ranging from 56 to 68 years. Head and
neck is the preferred site for DM; in the series from
the Massachusetts General Hospital, 75% of the tumors
occurred in this anatomic site [5]. None of our 5 cases had
a primary melanoma in the head and neck. The clinical
presentation of desmoplastic melanoma is often challenging.
Usually it has an innocuous clinical appearance and it is
described as an indurated discoid papule, plaque, or nodule.
Pigmentation is frequently absent (Figure 1), although a
lentigo or lentigo maligna-like discoloration adjacent to the
nodule is not uncommon [6]. The diagnoses that are sus-
pected clinically range from benign (scar, dermatoﬁbroma,
melanocytic nevus) to malignant (basal cell or squamous cell
carcinoma, sarcoma, or amelanotic melanoma) lesions. In
a series of 113 cases of desmoplastic melanoma melanoma
was the initial clinical diagosis in only 27% of the cases
[3].
Figure 1: Clinical appearance of desmoplastic melanoma (patient
n◦4): red plaque of 5 × 3cm on left leg. The diagnoses that are
suspected clinically range from basal cell carcinoma to dermatoﬁ-
brosarcoma protuberans or amelanotic melanoma.
There are no dermoscopic criteria for this rare neoplasm
probably because dermoscopic examination is not routinely
performed before excising a lesion that is often clinically
not considered as melanocytic. Debarbieux et al. reported
the dermoscopic features for six cases of desmoplastic
melanoma.Inthisshortseriesonlyhalfofthecasesexhibited
one classical feature of a melanocytic lesion while other cases
were recognized on the basis of the presence of ﬁgures of
regression (all six) such as white scar-like and “peppering”,
multiple(>4)colours(ﬁveoutofsix),andmelanoma-related
vascular patterns (ﬁve out of six) such as linear-irregular
vessels and milky-red areas [7]. The diagnosis of DM is
histopathological; the histology of classic DM (Figures 2 and
3) is deﬁned as a dermal-based, paucicellular proliferation of
atypical spindle cells in a sclerotic or neuromatous stroma
with evidence of melanocytic diﬀerentiation [8]. There
is histological subclassiﬁcation of DM into two variants:
pure desmoplastic melanoma (pDM) when desmoplasia is
prominent throughout the tumor and mixed desmoplastic
melanoma (mDM) when desmoplasia constitutes only a part
of an otherwise nondesmoplastic invasive melanoma.
ThemajorityofDMsarelargerthan1mminthicknessat
the time of diagnosis, and many tumors measure more than
4mm. This probably results from the diﬃculties in clinicalDermatology Research and Practice 3
Figure 2: Desmoplastic melanoma: atypical spindle cells in a dense
ﬁbous matrix (haematoxylin and eosin; original magniﬁcation
×10).
Figure 3: Desmoplastic melanoma: S-100 immunoreactivity in the
dermal spindle cells (original magniﬁcation ×10).
diagnosis. In our series, Breslow thickness ranged from 2.1 to
12mm with a mean thickness of 5.8mm. The role of SLNB
in the DM is not deﬁned as well. Several studies have shown
that patients with melanomas of desmoplastic type have a
lowerfrequencyofsentinelnodepositivitythanpatientswith
nondesmoplastic melanomas. In view of this, some authors
have advocated avoiding SLNB in patients with desmoplastic
melanoma [9–11]. 4 out of 5 patients underwent sentinel
lymph node biopsy and no patient was found to have a
positivesentinelnode.However,wethinkthatitisimportant
inthestageofthediseasewhenBreslowisequalorlargerthan
1mm. Assessment of nodal involvement allows indentifying
patientsatriskforlocoregionalrecurrence.LiteratureonDM
reports an incidence of “local recurrence” higher than the
one of conventional melanoma in patients with DM [1, 12–
15]. However, comparison of local recurrence rates between
DM and conventional melanomas is problematic. In most
seriesofrecurrentmelanoma,noattemptismadetoprecisely
deﬁne local recurrence and distinguish between persistent
melanomaandcutaneousmetastases[16].Withourpatients,
follow-up ranged from 2 to 113 months, with an average
of 49 months, and during follow-up period any patient had
disease progression or developed local recurrence. DM is a
rare neoplasm which clinically may mimic other tumours
or cutaneous inﬁltrate of uncertain signiﬁcance. Clinical
features, in fact, might be similar to melanoma but could
also be quite diﬀerent. The diagnosis is hiastopathological
and radical resection is necessary. Current controversies
regarding locoregional treatment strategies warrant further
investigation.
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